Objective: Adverse pregnancy outcomes, including preterm birth, are markedly higher among AfricanAmericans versus Whites. Stress-induced immune dysregulation may contribute to these effects. Epstein-Barr virus (EBV) reactivation provides a robust model for examining cellular immune competence. This study examined associations of EBV virus capsid antigen immunoglobulin G (VCA IgG) with gestational stage, race, and racial discrimination in women during pregnancy and postpartum. Methods: Fifty-six women (38 African-American, 18 White) were included. African-Americans and Whites did not differ in age, education, income, parity, or body mass index (ps P .51). During the 1st, 2nd, and 3rd trimester and $5 weeks postpartum, women completed measures of racial discrimination, perceived stress, anxiety, depressive symptoms and health behaviors. EBV VCA IgG antibody titers were measured via ELISA in serum collected at each visit. Results: In the overall sample, EBV VCA IgG antibody titers were lower in the 3rd versus 1st trimester (p = .002). At every timepoint (1st, 2nd, 3rd trimester and postpartum), African-American women exhibited higher serum EBV VCA IgG antibody titers than Whites (ps < .001). This effect was most pronounced among African-Americans reporting greater racial discrimination [p = .03 (1st), .04 (2nd), .12 (3rd), .06 (postpartum)]. Associations of race and racial discrimination with EBV VCA IgG antibody titers were not accounted for by other measures of stress or health behaviors. Conclusions: Compared to Whites, African-American women showed higher EBV VCA IgG antibody titers, indicative of impaired cellular immune competence, across pregnancy and postpartum. This effect was particularly pronounced among African-American women reporting greater racial discrimination, supporting a role for chronic stress in this association. In women overall, EBV antibody titers declined during late as compared to early pregnancy. This may be due to pregnancy-related changes in cell-mediated immune function, humoral immune function, and/or antibody transfer to the fetus in late gestation. As a possible marker of stress-induced immune dysregulation during pregnancy, the role of EBV reactivation in racial disparities in perinatal health warrants further attention.
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Introduction
Maternal stress during pregnancy has been associated with increased risk of adverse birth outcomes, but the mechanisms by which this occurs remain uncertain (Committee on Understanding Premature Birth and Assuring Healthy Outcomes, 2007). Stress constructs associated with risk of preterm birth include perceived stress, general distress, stressful life events, anxiety, and depressive symptoms (Committee on Understanding Premature Birth and Assuring Healthy Outcomes, 2007). Moreover, perceived racial discrimination has repeatedly been linked to increased risk of preterm delivery among African-American women (Rosenberg et al., 2002; Dole et al., 2003 Dole et al., , 2004 Collins et al., 2004; Mustillo et al., 2004) . Thus, the chronic stress of discriminated racial minority status has been implicated in the substantial racial disparities in preterm birth and low birth weight among African-American women versus women of other races/ethnicities in the US (Giscombe and Lobel, 2005) .
Given the linkage of stress to adverse pregnancy outcomes, an emerging literature is focusing on potential biological mechanisms for these associations. In terms of immune parameters, inflammatory markers have been a primary focus. Factors including
